U.S. Stock News

In the days leading up to its January 22, 2026 earnings release, Columbia Banking System drew attention as analysts projected year-over-year earnings and revenue increases while trimming consensus EPS estimates. The combination of expectations for improved quarterly performance and a negative Earnings ESP with a Zacks Rank of #4 highlighted a cautious tone around the likelihood of another earnings beat. With mixed analyst sentiment and downward EPS revisions in focus, we’ll now examine how...

Independent Bank Corporation recently declared a quarterly cash dividend of US$0.28 per share, payable on February 13, 2026, to shareholders of record on February 3, 2026, marking the thirteenth consecutive annual increase and highlighting its focus on ongoing cash returns to investors. This thirteenth straight annual dividend raise underscores the bank’s emphasis on capital strength and consistent shareholder payouts as a core part of its business profile. We’ll now examine how this latest...

If you are wondering whether Revolution Medicines at around US$120 per share reflects its real worth, you are not alone. This article is designed to help you frame that question clearly. The stock closed at US$120.28 recently, with returns of 1.4% over 7 days, 52.7% over 30 days, 52.2% year to date, 198.5% over 1 year and 337.1% over 3 years, which naturally raises questions about how expectations and risk are being priced in. Recent news flow around Revolution Medicines has focused on its...

Earlier this month, ORIC Pharmaceuticals presented its oncology pipeline at the 44th Annual J.P. Morgan Healthcare Conference, highlighting progress on ORIC-944 in metastatic castration-resistant prostate cancer and enozertinib for EGFR exon 20 insertion-positive non-small cell lung cancer. Investor interest has been reinforced by encouraging clinical data, provisional Phase 2 dosing decisions, and a collaboration with Johnson & Johnson to test enozertinib with amivantamab in first-line lung...

Cboe Global Markets (CBOE) has been in focus after reporting quarterly results that showed higher revenue and profit than a year earlier, which has increased analyst attention. The company also decided to close its Cboe Europe Derivatives exchange. See our latest analysis for Cboe Global Markets. At a share price of $273.55, Cboe Global Markets has seen firm momentum build recently, with a 10.63% 1 month share price return and a 15.38% 3 month share price return, while the 1 year total...

NioCorp Developments (NB) is back in focus after its board approved the Elk Creek Mine Portal Project and reported progress on financing, federal support, and scandium alloy production capacity. See our latest analysis for NioCorp Developments. Those mine portal and financing updates come after a very strong run for investors, with the latest 1 year total shareholder return above 300% and a recent 1 month share price return of 15.36% from a last close of US$6.61. However, the 3 month share...

In January 2026, American Eagle Outfitters raised its fourth-quarter 2025 operating income guidance to US$167 million–US$170 million, citing solid margins and anticipated consolidated comparable sales growth of 8%–9%, even after factoring in about US$50 million of tariff-related pressure. The guidance upgrade points to stronger-than-expected holiday performance and continued momentum at Aerie and Offline, where marketing campaigns appear to be lifting both sales mix and profitability. Next,...

SunOpta Inc. ( NASDAQ:STKL ) shareholders are no doubt pleased to see that the share price has bounced 25% in the last...

In early January 2026, Oshkosh Corporation highlighted a suite of AI-, autonomy-, connectivity- and electrification-enabled solutions across construction, waste management, firefighting and airport operations, while Oshkosh Defense secured new Common Bridge Transporter orders from the U.S. Army and additional Dutch Expeditionary Patrol Vehicle orders from the Netherlands Ministry of Defence. The acquisition of Canvas’s core robotics technology and the rollout of systems like HARR-E and the...

Apogee Enterprises, Inc.'s ( NASDAQ:APOG ) dividend will be increasing from last year's payment of the same period to...

It might be of some concern to shareholders to see the Atlanticus Holdings Corporation ( NASDAQ:ATLC ) share price down...

The Bank of New York Mellon Corporation ( NYSE:BK ) stock is about to trade ex-dividend in four days. The ex-dividend...

Balchem's (NASDAQ:BCPC) stock is up by a considerable 12% over the past three months. Since the market usually pay for...

Heritage Global Inc. ( NASDAQ:HGBL ) shareholders should be happy to see the share price up 15% in the last month. But...

Universal Electronics Inc. ( NASDAQ:UEIC ) shareholders are no doubt pleased to see that the share price has bounced...

Key Insights Significantly high institutional ownership implies Inseego's stock price is sensitive to their trading...

Recent insider activity at Louisiana-Pacific (LPX) has grabbed investor attention, with CEO William Bradley Southern selling US$6.39 million of stock under a pre-arranged 10b5-1 plan. See our latest analysis for Louisiana-Pacific. The recent insider sale comes as Louisiana-Pacific’s share price sits at US$93.14, with a 30-day share price return of 15.26% and a year-to-date share price return of 13.96%. The 1-year total shareholder return of 17.95% contrasts with much stronger 3-year and...

Analyst optimism around Customers Bancorp (CUBI) has picked up ahead of its December 2025 quarter results, as expectations for higher earnings intersect with stronger customer satisfaction signals at Customers Bank. See our latest analysis for Customers Bancorp. At a share price of US$78.46, Customers Bancorp has seen a 21.64% 90 day share price return, while its 1 year total shareholder return of 56.92% and 5 year total shareholder return of 248.25% point to strong longer term momentum. If...

CG Oncology (CGON) is back in focus after accelerating the topline data timeline for its Phase 3 PIVOT-006 trial, the first randomized study for intermediate-risk non muscle invasive bladder cancer patients. See our latest analysis for CG Oncology. The accelerated PIVOT-006 timeline sits against a strong recent run, with a 30 day share price return of 40.23% and a 1 year total shareholder return of 88.20%, suggesting momentum has been building around the story. If CG Oncology’s progress has...

Why US Foods Holding (USFD) Is Back on Investor Radar US Foods Holding (USFD) has drawn fresh attention after securing a maximum $198.26 million Defense Logistics Agency contract and reporting quarterly results that met revenue expectations while beating analyst EPS forecasts. See our latest analysis for US Foods Holding. The reaffirmed 2025 guidance, recent conference appearance, and new $198.26 million Defense Logistics Agency award have arrived alongside a 13.39% 7 day share price return...

In January 2026, AptarGroup announced that its LuerVax and Spray Divider nasal vaccine delivery systems are being used in CastleVax’s Phase II trial of the CVAX‑01 intranasal COVID‑19 vaccine, while also highlighting its expanding portfolio of preservative‑free and precision eye care technologies such as Beat the Blink in partnership with Bausch + Lomb. Together, these developments emphasize AptarGroup’s role as an enabling technology provider for next‑generation nasal and ophthalmic drug...

Earlier this week, UBS analyst Leonardo Olmos upgraded Millicom International Cellular (TIGO) to a buy rating, citing increased confidence in the company’s growth outlook as it expands telecom services across Latin America and pursues acquisitions in Ecuador and Uruguay. This shift in analyst sentiment highlights how Millicom’s regional expansion and service diversification are increasingly shaping market perceptions of its longer-term prospects. We’ll now examine how UBS’s renewed...

Earlier this month, BioCryst Pharmaceuticals, Inc. issued full-year 2026 earnings guidance, projecting total revenue between US$635,000,000 and US$660,000,000, following its presentation at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco. This new revenue outlook provides a clearer benchmark for how management currently views demand for its rare disease therapies and overall business trajectory. Now, we’ll consider how BioCryst’s newly issued 2026 revenue guidance range...

Alaska Air Group recently reaffirmed that the Alaska Airlines and Hawaiian Airlines brands will remain distinct while it expands its global footprint, including new long-haul routes from Seattle to London, Rome, Reykjavik, Tokyo and Seoul, with some services already operating and others scheduled to begin in 2026. At the same time, the company has warned that its upcoming fourth-quarter 2025 results, due January 22, were hurt by an IT outage, government shutdown-related revenue losses and...